MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 235 filers reported holding MYRIAD GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $202,000 | -13.3% | 5,400 | 0.0% | 0.04% | -16.7% |
| Q4 2015 | $233,000 | +15.3% | 5,400 | 0.0% | 0.04% | +10.5% |
| Q3 2015 | $202,000 | +1.0% | 5,400 | -4.4% | 0.04% | +8.6% |
| Q1 2015 | $200,000 | -9.9% | 5,650 | -1.7% | 0.04% | -14.6% |
| Q3 2014 | $222,000 | -2.6% | 5,750 | -1.7% | 0.04% | -4.7% |
| Q2 2014 | $228,000 | +14.0% | 5,850 | 0.0% | 0.04% | +4.9% |
| Q1 2014 | $200,000 | – | 5,850 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |